https://doi.org/10.1016/j.xgen.2022.100219
Y
Yuriko Otake
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
50
Papers
219
Citations
7
h-index
7
i10-index
Yuriko Otake is an academic researcher from Osaka Gakuin University. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Gastrointestinal disorders and treatments. The author has an h-index of 7, co-authored 43 publications.
ORCID: 0000-0001-8822-9544Papers by this author
worksProkaryotic and viral genomes recovered from 787 Japanese gut metagenomes revealed microbial features linked to diets, populations, and diseases
2022 · Cell Genomics · 35 citations
Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
2021 · BMC Cancer · 9 citations
https://doi.org/10.1186/s12885-021-08724-5
Leucine-rich Alpha-2 glycoprotein could be clinically useful in active and postoperative Crohn’s disease
2025 · Scientific Reports · 5 citations
https://doi.org/10.1038/s41598-025-93831-7
Sa1779 USEFULNESS OF SERUM LRG AS A BIOMARKER FOR EVALUATING WHOLE COLONIC INFLAMMATION OF ULCERATIVE COLITIS: A MULTICENTER PROSPECTIVE STUDY BY THE OSAKA GUT FORUM
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)01664-0
Su1804 PRETREATMENT LEVELS OF SERUM LEUCINE-RICH ALPHA-2 GLYCOPROTEIN IS USEFUL FOR SELECTION OF ANTI-CYTOKINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A MULTICENTER PROSPECTIVE COHORT STUDY BY THE OSAKA GUT FORUM
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)02368-0
EP25 SAFETY AND EFFECTIVENESS OF ORAL BUDESONIDE AFTER ENDOSCOPIC BALLON DILATION FOR INTESTINAL STENOSIS IN PATIENTS WITH CROHN'S DISEASE -A MULTICENTER PROSPECTIVE INTERVENTION STUDY
2024 · Gastroenterology · 0 citations
https://doi.org/10.1016/s0016-5085(24)03919-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat